PlainRecalls
FDA Devices Moderate Class II Terminated

Ablation Galil Technology, IceForce 2.1 CX 90 Cyroablation Needles, Prescription Only Galil Medicals 2.1 CX Cryoablation Needles are intended for cryoablative destruction of tissue during surgical procedures.

Reported: July 29, 2020 Initiated: June 4, 2020 #Z-2683-2020

Product Description

Ablation Galil Technology, IceForce 2.1 CX 90 Cyroablation Needles, Prescription Only Galil Medicals 2.1 CX Cryoablation Needles are intended for cryoablative destruction of tissue during surgical procedures.

Reason for Recall

The needle surface deteriorated due to unexpected electrolysis during procedure.

Details

Units Affected
656 devices
Distribution
Nationwide Distribution to states of: AL, AR, AZ, CA, CO, CT, DE, DC, FL, GA, HI, IA, ID, KS, LA, MA, MD, ME, MN, MO, MS, NC, ND, NE, NJ, NM, NY, NV, OH, OK, OR, PA, RI, SC, SD, TN, TX, UT, VA, WA, WI WV, and WY and the country of: Canada.
Location
Marlborough, MA

Frequently Asked Questions

What product was recalled?
Ablation Galil Technology, IceForce 2.1 CX 90 Cyroablation Needles, Prescription Only Galil Medicals 2.1 CX Cryoablation Needles are intended for cryoablative destruction of tissue during surgical procedures.. Recalled by Boston Scientific Corporation. Units affected: 656 devices.
Why was this product recalled?
The needle surface deteriorated due to unexpected electrolysis during procedure.
Which agency issued this recall?
This recall was issued by the FDA Devices on July 29, 2020. Severity: Moderate. Recall number: Z-2683-2020.